clinical decision making with immunotherapies in advanced or recurrent endometrial cancer
Published 3 months ago • 186 plays • Length 37:54Download video MP4
Download video MP3
Similar videos
-
13:29
implementation of immune checkpoint inhibitors in endometrial cancer through shared decision making
-
1:00:25
expanding horizons in the treatment of endometrial cancer: esgo 2023 guide clinical practice?
-
27:39
immunotherapy approaches in front-line advanced/recurrent endometrial cancer
-
57:40
immunotherapy in endometrial cancer: expanding horizons
-
5:22
two landmark papers change treatment paradigm for advanced endometrial cancer
-
36:12
evolving medical treatment in advanced / recurrent endometrial cancer
-
32:23
shifting the focus to locally advanced cervical cancer: improving patient outcomes through teamwork
-
6:07
evolving medical treatment in advanced/recurrent endometrial cancer
-
0:47
assessing chemotherapy and immunotherapy in dmmr endometrial cancer
-
20:43
updates in advanced & recurrent endometrial cancer: molecular classification & emerging therapies
-
36:22
modern, molecularly informed therapy for patients with advanced endometrial cancer
-
52:53
immunotherapy in advanced endometrial cancer – the new standard of care
-
3:52
treatment of advanced endometrial cancer
-
1:00
precision oncology in endometrial cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
13:55
masterclass on conservative treatment in endometrial cancer
-
19:55
new immunotherapy for endometrial cancer patients | osuccc – james
-
1:12
impact of genomic testing on treatment decision-making in breast cancer
-
1:16
dr. irina tunnage – service specific (endometrial cancer)